Should I buy or sell Inotiv stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inotiv in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" NOTV shares. View NOTV analyst ratings or view top-rated stocks .

What is Inotiv's stock price target for 2024?

3 equities research analysts have issued 1-year target prices for Inotiv's stock. Their NOTV share price targets range from $8.00 to $34.00. On average, they expect the company's share price to reach $15.25 in the next year. This suggests a possible upside of 351.2% from the stock's current price. View analysts price targets for NOTV or view top-rated stocks among Wall Street analysts .

How have NOTV shares performed in 2023?

Inotiv's stock was trading at $4.94 at the start of the year. Since then, NOTV stock has decreased by 31.6% and is now trading at $3.38. View the best growth stocks for 2023 here .

When is Inotiv's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, December 11th 2023. View our NOTV earnings forecast .

How can I listen to Inotiv's earnings call?

Inotiv will be holding an earnings conference call on Monday, December 11th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link .

How were Inotiv's earnings last quarter?

Inotiv, Inc. (NASDAQ:NOTV) announced its quarterly earnings results on Thursday, December, 16th. The company reported ($0.23) earnings per share for the quarter, missing analysts' consensus estimates of ($0.13) by $0.10. The business had revenue of $30.08 million for the quarter. Inotiv had a negative net margin of 58.34% and a negative trailing twelve-month return on equity of 14.14%. During the same period in the previous year, the company earned ($0.16) earnings per share.

Who are Inotiv's major shareholders?

Inotiv's stock is owned by a number of institutional and retail investors. Top institutional shareholders include AQR Capital Management LLC (1.58%), Fuller & Thaler Asset Management Inc. (1.23%), Oak Family Advisors LLC (0.57%), GSA Capital Partners LLP (0.45%), KPP Advisory Services LLC (0.44%) and Kennedy Capital Management LLC (0.15%). Insiders that own company stock include Gregory Cole Davis, James Harkness, John E Sagartz, John E Sagartz , John Gregory Beattie, Michael Garrett, Philip A Downing , R Matthew Neff, Robert Jr Leasure and William D Pitchford. View institutional ownership trends .

How do I buy shares of Inotiv?

Shares of NOTV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Inotiv Stock Price, News & Analysis (NASDAQ:NOTV)

$3.38

+0.28 (+9.03%)

(As of 12/8/2023 ET)

Compare

Today's Range: $3.06
▼
$3.38
50-Day Range: $1.69
▼
$3.38
52-Week Range: $1.61
▼
$8.88

Volume: 208,078 shs
Average Volume: 199,195 shs
Market Capitalization: $87.15 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $15.25

Inotiv MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.67 Rating Score
Upside/Downside: 351.2% Upside
$15.25 Price Target
Short Interest: Healthy
4.83% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.11
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.89 out of 5 stars

Medical Sector

615th out of 933 stocks

Commercial Physical Research Industry

11th out of 13 stocks

3.3

Analyst's Opinion

Consensus Rating
Inotiv has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $15.25, Inotiv has a forecasted upside of 351.2% from its current price of $3.38.
Amount of Analyst Coverage
Inotiv has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
4.83% of the float of Inotiv has been sold short.
Short Interest Ratio / Days to Cover
Inotiv has a short interest ratio ("days to cover") of 4.5.
Change versus previous month
Short interest in Inotiv has recently decreased by 9.38%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Inotiv does not currently pay a dividend.
Dividend Growth
Inotiv does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NOTV.

1.7

News and Social Media Coverage

News Sentiment
Inotiv has a news sentiment score of 0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Inotiv this week, compared to 1 article on an average week.
Search Interest
Only 2 people have searched for NOTV on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Inotiv to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Inotiv insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 5.80% of the stock of Inotiv is held by insiders.
Percentage Held by Institutions
Only 30.30% of the stock of Inotiv is held by institutions.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Inotiv is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Inotiv is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Inotiv has a P/B Ratio of 0.24. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Inotiv Stock (NASDAQ:NOTV)

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment, Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company offers research and discovery services including, computational toxicology, disease pharmacology, DMPK, safety pharmacology, discovery bioanalysis, exploratory, surgical models and medical device, and cell and molecular biology; non-clinical safety assessment includes, general and genetic toxicology, regulated bioanalysis, biotherapeutics, and development and reproductive toxicology; pathology services, such as histology, digital, clinical, and medical device pathology; bioanalysis includes, nonregulated discovery bioanalysis, biotherapeutics, and regulated preclinical and clinical bioanalysis; proteomics; and consulting services. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

NOTV Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NOTV Stock News Headlines

December 8, 2023 | benzinga.com

Inotiv's Earnings Outlook

December 6, 2023 | msn.com

Inotiv plans to insource North American transportation operations

December 10, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

December 6, 2023 | finance.yahoo.com

Inotiv, Inc. Announces Plan to Insource North American Transportation Operations

December 4, 2023 | americanbankingnews.com

Inotiv (NOTV) to Release Quarterly Earnings on Monday

December 1, 2023 | americanbankingnews.com

Inotiv (NASDAQ:NOTV) Trading Down 3.1%

November 27, 2023 | finance.yahoo.com

Inotiv, Inc. to Report Fiscal 2023 Fourth Quarter and Full Year Results and Host Conference Call on Monday, December 11, 2023

November 13, 2023 | finance.yahoo.com

Inotiv Provides Business Updates and Upcoming Investor Conferences Update

December 10, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

October 25, 2023 | finance.yahoo.com

Inotiv, Inc. (BS50.F)

October 16, 2023 | finance.yahoo.com

Inotiv, Inc. Announces Changes to its Board Composition

October 15, 2023 | finance.yahoo.com

Investors are selling off Inotiv (NASDAQ:NOTV), lack of profits no doubt contribute to shareholders one-year loss

October 9, 2023 | finance.yahoo.com

Inotiv, Inc. (NOTV) Stock Historical Prices & Data - Yahoo Finance

August 30, 2023 | finanznachrichten.de

Inotiv, Inc.: Inotiv Announces the Sale of its Israeli Businesses to Harlan Holdings Ltd.

August 30, 2023 | seekingalpha.com

Inotiv up 3%, sells Israeli businesses to Harlan

August 29, 2023 | finance.yahoo.com

Inotiv Announces the Sale of its Israeli Businesses to Harlan Holdings Ltd.

August 24, 2023 | finance.yahoo.com

Inotiv, Inc. to Participate in Upcoming September 2023 Investor Conferences

August 15, 2023 | benzinga.com

Inotiv, Inc. (NOTV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

August 11, 2023 | markets.businessinsider.com

Lake Street Keeps Their Buy Rating on Inotiv (NOTV)

August 11, 2023 | finanznachrichten.de

Inotiv, Inc.: Inotiv Reports Third Quarter Financial Results for Fiscal 2023 and Provides Business Update

August 10, 2023 | finance.yahoo.com

Inotiv, Inc. (NOTV) Q3 Earnings Miss Estimates

August 10, 2023 | finance.yahoo.com

Inotiv Reports Third Quarter Financial Results for Fiscal 2023 and Provides Business Update

July 24, 2023 | finance.yahoo.com

Inotiv, Inc. to Report Fiscal 2023 Third Quarter Financial Results and Host Conference Call on Thursday, August 10, 2023

July 21, 2023 | finance.yahoo.com

Strength Seen in Inotiv, Inc. (NOTV): Can Its 34.5% Jump Turn into More Strength?

July 20, 2023 | msn.com

Wells Fargo Initiates Coverage of Inotiv (NOTV) with Overweight Recommendation

June 30, 2023 | finance.yahoo.com

Are Options Traders Betting on a Big Move in Inotiv (NOTV) Stock?

June 5, 2023 | finance.yahoo.com

Does Inotiv, Inc. (NOTV) Have the Potential to Rally 185.14% as Wall Street Analysts Expect?

See More Headlines

Receive NOTV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inotiv and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 12/16/2021
Today: 12/10/2023
Next Earnings (Confirmed): 12/11/2023
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial physical research
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:NOTV
CUSIP: N/A
CIK: 720154
Web: www.inotivco.com
Phone: (765) 463-4527
Fax: 765-497-1102
Employees: 2,204
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $15.25
High Stock Price Target: $34.00
Low Stock Price Target: $8.00
Potential Upside/Downside: +351.2%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.67
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($13.27)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-337,020,000.00
Net Margins: -58.34%
Pretax Margin: -63.60%
Return on Equity: -14.14%
Return on Assets: -4.72%

Debt

Debt-to-Equity Ratio: 1.35
Current Ratio: 1.68
Quick Ratio: 1.23

Sales & Book Value

Annual Sales: $582.15 million
Price / Sales: 0.15
Cash Flow: $1.22 per share
Price / Cash Flow: 2.76
Book Value: $14.06 per share
Price / Book: 0.24

Miscellaneous

Outstanding Shares: 25,783,000
Free Float: 24,288,000
Market Cap: $87.15 million
Optionable: Not Optionable
Beta: 2.64

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Robert W. Leasure Jr. (Age 63)
President, CEO & Director
Comp: $1.69M
Ms. Beth A. Taylor CPA (Age 58)
Senior VP of Finance & CFO
Comp: $457.57k
Dr. Adrian Hardy Ph.D. (Age 52)
Executive VP of Global Marketing & Corporate Development
Comp: $2.74M
Dr. John E. Sagartz D.V.M. (Age 57)
DiplomateACVP, Ph.D., Chief Strategy Officer & Director
Comp: $443.85k
Dr. Peter T. Kissinger (Age 78)
Founder, Chairman Emeritus & Scientific Advisor
Comp: $330.12k
Mr. John Gregory Beattie DSA (Age 55)
Chief Operating Officer
Mr. Brennan Freeman (Age 35)
VP of Finance, Principal Accounting Officer & Corporate Controller
Mr. Mo Dastagir (Age 46)
Chief Technology Officer
Ms. Andrea Castetter
Senior VP of General Counsel & Corporate Secretary
Ms. Kimberly Beaty
Senior Director of Marketing

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NOTV Stock Analysis - Frequently Asked Questions

Should I buy or sell Inotiv stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inotiv in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" NOTV shares.
View NOTV analyst ratings or view top-rated stocks.
What is Inotiv's stock price target for 2024?: 3 equities research analysts have issued 1-year target prices for Inotiv's stock. Their NOTV share price targets range from $8.00 to $34.00. On average, they expect the company's share price to reach $15.25 in the next year. This suggests a possible upside of 351.2% from the stock's current price.
View analysts price targets for NOTV or view top-rated stocks among Wall Street analysts.
How have NOTV shares performed in 2023?: Inotiv's stock was trading at $4.94 at the start of the year. Since then, NOTV stock has decreased by 31.6% and is now trading at $3.38.
View the best growth stocks for 2023 here.
When is Inotiv's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, December 11th 2023.
View our NOTV earnings forecast.

How can I listen to Inotiv's earnings call?: Inotiv will be holding an earnings conference call on Monday, December 11th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.
How were Inotiv's earnings last quarter?: Inotiv, Inc. (NASDAQ:NOTV) announced its quarterly earnings results on Thursday, December, 16th. The company reported ($0.23) earnings per share for the quarter, missing analysts' consensus estimates of ($0.13) by $0.10. The business had revenue of $30.08 million for the quarter. Inotiv had a negative net margin of 58.34% and a negative trailing twelve-month return on equity of 14.14%. During the same period in the previous year, the company earned ($0.16) earnings per share.
Who are Inotiv's major shareholders?: Inotiv's stock is owned by a number of institutional and retail investors. Top institutional shareholders include AQR Capital Management LLC (1.58%), Fuller & Thaler Asset Management Inc. (1.23%), Oak Family Advisors LLC (0.57%), GSA Capital Partners LLP (0.45%), KPP Advisory Services LLC (0.44%) and Kennedy Capital Management LLC (0.15%). Insiders that own company stock include Gregory Cole Davis, James Harkness, John E Sagartz, John E Sagartz, John Gregory Beattie, Michael Garrett, Philip A Downing, R Matthew Neff, Robert Jr Leasure and William D Pitchford.
View institutional ownership trends.
How do I buy shares of Inotiv?: Shares of NOTV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:NOTV) was last updated on 12/10/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial